Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Peter Ashley Marks currently holds 191,340 shares of ALTERITY THERAPEUTICS LTD (ATHE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter Ashley Marks has been a net buyer of ATHE stock. They have purchased $47.6K and sold $0 worth of shares.
Peter Ashley Marks's most recent insider trade was on Aug 31, 2026, when they purchased 47,620 shares at $0.50 per share.
Peter Ashley Marks serves as Executive at ALTERITY THERAPEUTICS LTD (ATHE). They have executed 2 insider transactions totaling $47.6K over their tenure at the company.
Peter Ashley Marks holds the position of Executive at ALTERITY THERAPEUTICS LTD, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Peter Ashley Marks has shown a buying trading pattern, with $47.6K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Peter Ashley Marks was on Aug 31, 2026, when they purchased $23.8K worth of ATHE shares. This transaction involved 47,620 shares at $0.50 per share.
Peter Ashley Marks currently owns 191,340 shares of ALTERITY THERAPEUTICS LTD (ATHE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Peter Ashley Marks's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Peter Ashley Marks has 2 Form 4 filings on record as an insider at ALTERITY THERAPEUTICS LTD.
Set alerts for Peter Ashley Marks and 40,000+ other insiders.